Evidence for Bone and Mineral Metabolism Alterations in Children With Autosomal Dominant Polycystic Kidney Disease
Stéphanie De Rechter(KU Leuven), Djalila Mekahli(KU Leuven), Julie Maquet(Centre Hospitalier Chrétien), Elena Levtchenko(Emma Kinderziekenhuis), Pierre Cochat(Société Nationale des Chemins de Fer Français (France)), Pieter Vermeersch(Universitair Ziekenhuis Leuven), Jean De Schepper(Antwerp University Hospital), Laurence Dubourg(Lyon 1 Université), Patrick D’Haese(University of Antwerp), Nathalie Godefroid(UCLouvain), Pieter Evenepoel(KU Leuven), Ann Raes, Maria Van Dyck(KU Leuven), Justine Bacchetta(Université Claude Bernard Lyon 1)
Cited by 20
Related Papers
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
|New England Journal of Medicine|2004|1.1k
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
|Kidney International|2017|998
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|509
An estimated glomerular filtration rate equation for the full age spectrum
|Nephrology Dialysis Transplantation|2016|489
Uremic toxins originating from colonic microbial metabolism
|Kidney International|2009|442